SCHEMBL26378679

SCHEMBL26378679

COc1cc(CC(=O)Nc2ccc(F)c(-c3cccc(O)c3)c2)ccc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 6/20 0.51
SMN1; SMN2 Q16637 6/20 0.48
LMNA P02545 5/20 0.48
HTT P42858 4/20 0.48
KMT2A Q03164 2/20 0.48
STAT3 P40763 2/20 0.47
EPHX2 P34913 1/20 0.47
FBP1 P09467 2/20 0.46
NPSR1 Q6W5P4 5/20 0.46
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 4/20 0.46
TSHR P16473 4/20 0.46
MAPT P10636 3/20 0.46
MAPK1 P28482 3/20 0.46
MEN1 O00255 1/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 1/20 0.46
POLB P06746 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
TP53 P04637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25769880 0.86 NLRP3 (0.61) NLRP3SMN1; SMN2LMNAHTTKMT2A
SCHEMBL25293876 0.85 SMN1; SMN2 (0.45) NLRP3SMN1; SMN2LMNAHTTKMT2A
SCHEMBL25769883 0.80 NLRP3 (0.51) NLRP3SMN1; SMN2LMNAHTTKMT2A
SCHEMBL26378655 0.79 SMN1; SMN2 (0.57) NLRP3SMN1; SMN2LMNAHTTKMT2A
SCHEMBL6101644 0.79 SMN1; SMN2 (0.64) NLRP3SMN1; SMN2LMNAHTTKMT2A
SCHEMBL6099937 0.78 ALDH1A1 (0.65) SMN1; SMN2LMNAHTTKMT2AEPHX2
SCHEMBL25769888 0.76 LMNA (0.57) NLRP3SMN1; SMN2LMNAHTTKMT2A
SCHEMBL6098990 0.75 SMN1; SMN2 (0.60) NLRP3SMN1; SMN2LMNAHTTKMT2A
SCHEMBL6100978 0.74 KDM4E (0.65) NLRP3SMN1; SMN2LMNAHTTKMT2A
SCHEMBL6100235 0.74 BCHE (0.65) SMN1; SMN2LMNAHTTKMT2AEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312474-A1 PHENOL DERIVATIVE Sumitomo Pharma Co., Ltd. (JP) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230312474-A1 PHENOL DERIVATIVE TYR, NCOR1, BET1 NLRP3 599/4885SMN1; SMN2 2949/4885LMNA 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.